CANF

Can-Fite Biopharma Ltd ADR

$2.92

-0.01 (-0.34%)

Analyst Overview

Target Price:

Date: 13.04.2026

$50.00

(+1612.33%)

Strong Buy: 0

Buy: 1

Hold: 1

Sell: 0

Strong Sell: 0

Description:

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutics for the treatment of cancer, liver and inflammatory diseases, COVID-19, and erectile dysfunction. The company is headquartered in Petah-Tikva, Israel.

Exchange:

NYSE MKT

Country:

USA

Sector:

HEALTHCARE

Industry:

BIOTECHNOLOGY

Address:

26 BEN GURION STREET, RAMAT GAN, ISRAEL, 5257346

Fiscal year end:

December

Market capitalization:

$6.85 Million

EBITDA:

-$9.93 Million

PERatio:

0.0

EPS:

-10.75

Dividend per share:

$0.00

Dividend yield:

0.0%

Beta:

-0.101

Dividends for 10 years

Income Statements for 10 years

Earnings calender

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:

$1,000

How much will you earn in 10 years:

-100%

How much will you get:

Prices dates:

31-03-2016: $8,370.00 and 31-03-2026: $3.10